{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:24:44Z","timestamp":1787012684473,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005230","name":"The Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["GSTB2023NSCQ-MSX0491"],"award-info":[{"award-number":["GSTB2023NSCQ-MSX0491"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05957-9","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:14:56Z","timestamp":1781169296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics, antithrombotic strategies, and outcomes in patients with atrial fibrillation and coronary heart disease undergoing percutaneous coronary intervention: a multicenter real-world study in Chongqing, China"],"prefix":"10.1186","volume":"26","author":[{"given":"Naiyue","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6116-627X","authenticated-orcid":false,"given":"Hua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"5957_CR1","doi-asserted-by":"publisher","unstructured":"The relationship between atrial fibrillation and coronary artery disease: Understanding common denominators. Trends Cardiovasc Med. 2024;34(2):91-98. https:\/\/doi.org\/10.1016\/j.tcm.2022.09.006.","DOI":"10.1016\/j.tcm.2022.09.006"},{"key":"5957_CR2","doi-asserted-by":"publisher","unstructured":"Patients with atrial fibrillation and coronary artery disease \u2013 double trouble. Adv Med Sci. 2018;63(1):31-35. https:\/\/doi.org\/10.1016\/j.advms.2017.06.005","DOI":"10.1016\/j.advms.2017.06.005"},{"key":"5957_CR3","doi-asserted-by":"publisher","unstructured":"T C, M K, Ep N, G W, V K. Role of percutaneous coronary intervention in the modern-day management of chronic coronary syndrome. Heart (Br Card Soc). 2023;109(19). https:\/\/doi.org\/10.1136\/heartjnl-2022-321870.","DOI":"10.1136\/heartjnl-2022-321870"},{"key":"5957_CR4","doi-asserted-by":"publisher","unstructured":"Romiti GF, Proietti M, Bonini N, et al. Adherence to the atrial fibrillation better care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF registry. eClinicalMedicine. 2022;55:101757. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101757.","DOI":"10.1016\/j.eclinm.2022.101757"},{"key":"5957_CR5","doi-asserted-by":"publisher","unstructured":"Js L, Je TH, S B, et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: Executive summary: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation. 2022;145(3). https:\/\/doi.org\/10.1161\/CIR.0000000000001039.","DOI":"10.1161\/CIR.0000000000001039"},{"key":"5957_CR6","doi-asserted-by":"publisher","unstructured":"L M, D F, I F, et al. Antiplatelet therapy in patients requiring oral anticoagulation and undergoing percutaneous coronary intervention. Interv Cardiol Clin. 2024;13(4). https:\/\/doi.org\/10.1016\/j.iccl.2024.07.001.","DOI":"10.1016\/j.iccl.2024.07.001"},{"key":"5957_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq117","author":"Gy L","year":"2010","unstructured":"L Gy, H K, A F, et al. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing coronary stenting: executive summary--a consensus document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2010. https:\/\/doi.org\/10.1093\/eurheartj\/ehq117.","journal-title":"Eur Heart J"},{"key":"5957_CR8","doi-asserted-by":"publisher","unstructured":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial. Lancet. 2013;381(9872):1107-1115. https:\/\/doi.org\/10.1016\/S0140-6736(12)62177-1","DOI":"10.1016\/S0140-6736(12)62177-1"},{"key":"5957_CR9","doi-asserted-by":"publisher","unstructured":"M V, H B, Ra B, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The task force for dual antiplatelet therapy in coronary artery disease of the european society of cardiology (ESC) and of the european association for cardio-thoracic surgery (EACTS). Eur Heart J. 2018;39(3). https:\/\/doi.org\/10.1093\/eurheartj\/ehx419.","DOI":"10.1093\/eurheartj\/ehx419"},{"key":"5957_CR10","doi-asserted-by":"publisher","unstructured":"Gyh L, Jp C, M H, et al. 2018 joint european consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing percutaneous cardiovascular interventions: A joint consensus document of the european heart rhythm association (EHRA), european society of cardiology working group on thrombosis, european association of percutaneous cardiovascular interventions (EAPCI), and european association of acute cardiac care (ACCA) endorsed by the heart rhythm society (HRS), asia-pacific heart rhythm society (APHRS), latin America heart rhythm society (LAHRS), and cardiac arrhythmia society of southern africa (CASSA). Eur\u202f: Eur Pacing Arrhythm Card Electrophysiol\u202f: J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2019;21(2). https:\/\/doi.org\/10.1093\/europace\/euy174.","DOI":"10.1093\/europace\/euy174"},{"key":"5957_CR11","doi-asserted-by":"publisher","unstructured":"Management of antithrombotic therapy in atrial fibrillation patients undergoing PCI: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(1):83-99. https:\/\/doi.org\/10.1016\/j.jacc.2019.05.016.","DOI":"10.1016\/j.jacc.2019.05.016"},{"key":"5957_CR12","doi-asserted-by":"publisher","unstructured":"Triple antithrombotic therapy versus dual antiplatelet...\u202f: coronary artery disease. LWW. https:\/\/doi.org\/10.1097\/MCA.0000000000000242.","DOI":"10.1097\/MCA.0000000000000242"},{"key":"5957_CR13","unstructured":"Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment | herz. Accessed 20 July 2025. http:\/\/link-springer-com-s.swebvpn.cqmu.edu.cn:8118\/article\/10.1007\/s00059-015-4325-0."},{"key":"5957_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2023.08.002","author":"R M","year":"2023","unstructured":"M R, W Hy, Y Ym, Z H, S N, W Jy. Implications of bleeding on subsequent cardiovascular events in patients with atrial fibrillation after acute coronary syndrome or PCI. Thromb Res. 2023. https:\/\/doi.org\/10.1016\/j.thromres.2023.08.002.","journal-title":"Thromb Res"},{"key":"5957_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.1038","author":"K T","year":"2018","unstructured":"T K, A Js, J As, et al. Fourth universal definition of myocardial infarction. J Am Coll Cardiol. 2018. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1038.","journal-title":"J Am Coll Cardiol"},{"key":"5957_CR16","doi-asserted-by":"publisher","unstructured":"Rl S, Se K, Jp B, et al. An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American heart association\/american stroke association. Stroke. 2013;44(7). https:\/\/doi.org\/10.1161\/STR.0b013e318296aeca.","DOI":"10.1161\/STR.0b013e318296aeca"},{"key":"5957_CR17","doi-asserted-by":"publisher","unstructured":"Wj D, T O, Fw V, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial. Lancet (Lond Engl). 2013;381(9872). https:\/\/doi.org\/10.1016\/S0140-6736(12)62177-1","DOI":"10.1016\/S0140-6736(12)62177-1"},{"key":"5957_CR18","doi-asserted-by":"publisher","unstructured":"Fj N, M SU, A A, et al. 2018 ESC\/EACTS guidelines on myocardial revascularization. EuroIntervention\u202f: J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol. 2019;14(14). https:\/\/doi.org\/10.4244\/EIJY19M01_01.","DOI":"10.4244\/EIJY19M01_01"},{"key":"5957_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-020-01609-8","volume":"20","author":"L Wei","year":"2020","unstructured":"Wei L, Su E, Liu W, et al. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation. BMC Cardiovasc Disord. 2020;20:323. https:\/\/doi.org\/10.1186\/s12872-020-01609-8.","journal-title":"BMC Cardiovasc Disord"},{"key":"5957_CR20","doi-asserted-by":"publisher","DOI":"10.1253\/circrep.CR-23-0047","author":"Y N","year":"2023","unstructured":"N Y, M T, Y M, et al. Temporal trends in antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention from 2014 to 2022 in Japan. Circ Rep. 2023. https:\/\/doi.org\/10.1253\/circrep.CR-23-0047.","journal-title":"Circ Rep"},{"key":"5957_CR21","doi-asserted-by":"publisher","unstructured":"Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the japanese college of cardiology. J Cardiol. 2018;72(2):113-119. https:\/\/doi.org\/10.1016\/j.jjcc.2018.01.017.","DOI":"10.1016\/j.jjcc.2018.01.017"},{"key":"5957_CR22","doi-asserted-by":"publisher","unstructured":"Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation. US Cardiol. 2021;15:e10. https:\/\/doi.org\/10.15420\/usc.2020.31.","DOI":"10.15420\/usc.2020.31"},{"key":"5957_CR23","doi-asserted-by":"publisher","unstructured":"Antithrombotic Therapy in Patients with Complex Percutaneous Coronary Intervention and Cardiogenic Shock. Interv Cardiol Clin. 2024;13(4):517\u201325. https:\/\/doi.org\/10.1016\/j.iccl.2024.06.006.","DOI":"10.1016\/j.iccl.2024.06.006"},{"key":"5957_CR24","doi-asserted-by":"publisher","unstructured":"Ds C, A O, G A, et al. Antithrombotic therapy in complex percutaneous coronary intervention. EuroIntervention\u202f: J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol. 2025;21(18). https:\/\/doi.org\/10.4244\/EIJ-D-24-00992.","DOI":"10.4244\/EIJ-D-24-00992"},{"key":"5957_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae177","author":"C V","year":"2024","unstructured":"V C, A F, K Kc, et al. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024. https:\/\/doi.org\/10.1093\/eurheartj\/ehae177.","journal-title":"Eur Heart J"},{"key":"5957_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.068","author":"M V","year":"2016","unstructured":"V M, B Dl, C Bl, et al. Proton-pump inhibitors reduce gastrointestinal events regardless of aspirin dose in patients requiring dual antiplatelet therapy. J Am Coll Cardiol. 2016. https:\/\/doi.org\/10.1016\/j.jacc.2015.12.068.","journal-title":"J Am Coll Cardiol"},{"key":"5957_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-024-04029-0","author":"Bk P","year":"2024","unstructured":"P Bk, K Mn, Z Qs, et al. Adverse cardiovascular outcomes associated with proton pump inhibitor use after percutaneous coronary intervention: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2024. https:\/\/doi.org\/10.1186\/s12872-024-04029-0.","journal-title":"BMC Cardiovasc Disord"},{"key":"5957_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/00001573-200107000-00001","author":"Cj V","year":"2001","unstructured":"V Cj, D N, B Ct. Statin therapy and stroke prevention. Curr Opin Cardiol. 2001. https:\/\/doi.org\/10.1097\/00001573-200107000-00001.","journal-title":"Curr Opin Cardiol"},{"key":"5957_CR29","doi-asserted-by":"publisher","unstructured":"S T, J W, Hy L, G S, S S. Balancing thrombosis and bleeding: Antithrombotic therapy in cirrhosis-related thrombocytopenia. J Clin Med. 2026;15(5). https:\/\/doi.org\/10.3390\/jcm15052036.","DOI":"10.3390\/jcm15052036"},{"key":"5957_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13775","author":"J Z","year":"2023","unstructured":"Z J, W X, Y J, et al. An analysis of antithrombotic therapy in elderly patients with atrial fibrillation undergoing percutaneous coronary interventions. Clin Exp Pharmacol Physiol. 2023. https:\/\/doi.org\/10.1111\/1440-1681.13775.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"5957_CR31","doi-asserted-by":"publisher","unstructured":"Mr DT, M Q, Jlp T, et al. Left atrial volume and cardiovascular outcomes in systolic heart failure: Effect of antithrombotic treatment. ESC Heart Fail. 2018;5(5). https:\/\/doi.org\/10.1002\/ehf2.12331.","DOI":"10.1002\/ehf2.12331"},{"key":"5957_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.03.012","author":"I H","year":"2018","unstructured":"H I, Z Y, S S. Effectiveness and safety of direct oral anticoagulants and warfarin, stratified by stroke risk in patients with atrial fibrillation. Am J Cardiol. 2018. https:\/\/doi.org\/10.1016\/j.amjcard.2018.03.012.","journal-title":"Am J Cardiol"},{"key":"5957_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-05042-7","author":"Y W","year":"2025","unstructured":"W Y, W J, S Y, X Y, Y Y. The impact of atrial fibrillation type on clinical outcomes and antithrombotic therapy at discharge in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a real-world study. BMC cardiovascular disorders. 2025. https:\/\/doi.org\/10.1186\/s12872-025-05042-7.","journal-title":"BMC cardiovascular disorders"},{"key":"5957_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae176","author":"Ic Vg","year":"2024","unstructured":"Vg Ic, R M, B Kv, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176.","journal-title":"Eur Heart J"},{"key":"5957_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2018.1521721","author":"A C","year":"2018","unstructured":"C A, I A, K Tj. Triple antithrombotic therapy in patients with atrial fibrillation undergoing PCI: current evidence and practice. Expert Rev Cardiovasc Ther. 2018. https:\/\/doi.org\/10.1080\/14779072.2018.1521721.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"5957_CR36","doi-asserted-by":"publisher","DOI":"10.1177\/1753944710391925","author":"Pp S","year":"2011","unstructured":"S Pp, S M, B U, M J, A R, K S. Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation. Ther Adv Cardiovasc Dis. 2011. https:\/\/doi.org\/10.1177\/1753944710391925.","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"5957_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.123.013242","author":"T K","year":"2023","unstructured":"K T, W A, S S, et al. Short-term DAPT and DAPT de-escalation strategies for patients with acute coronary syndromes: a systematic review and network meta-analysis. Circ, Cardiovasc Interv. 2023. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.123.013242.","journal-title":"Circ, Cardiovasc Interv"},{"key":"5957_CR38","doi-asserted-by":"publisher","unstructured":"H C, Q S, H L, T T, J S, Y L. Observation of bleeding and MACCE events in patients with liver cirrhosis complicated with acute coronary syndrome after antiplatelet therapy. J Coll Physicians Surg--Pak\u202f: JCPSP. 2023;33(8). https:\/\/doi.org\/10.29271\/jcpsp.2023.08.927.","DOI":"10.29271\/jcpsp.2023.08.927"},{"key":"5957_CR39","unstructured":"Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention - PubMed. Accessed March 23, 2026. http:\/\/pubmed-ncbi-nlm-nih-gov-s.swebvpn.cqmu.edu.cn:8118\/32887588\/."},{"key":"5957_CR40","doi-asserted-by":"publisher","unstructured":"P G, V R, Jm T, et al. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Circ, Arrhythmia Electrophysiol. 2012;5(2). https:\/\/doi.org\/10.1161\/CIRCEP.111.967000.","DOI":"10.1161\/CIRCEP.111.967000"},{"key":"5957_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1429900","author":"B F","year":"2024","unstructured":"F B, R B, Z D, et al. Implications of anemia in patients undergoing PCI with Impella-support: insights from the PROTECT III study. Front Cardiovasc Med. 2024. https:\/\/doi.org\/10.3389\/fcvm.2024.1429900.","journal-title":"Front Cardiovasc Med"},{"key":"5957_CR42","unstructured":"Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery - PubMed. Accessed March 23, 2026. http:\/\/pubmed-ncbi-nlm-nih-gov-s.swebvpn.cqmu.edu.cn:8118\/16872968\/."}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05957-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05957-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05957-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:31:46Z","timestamp":1787009506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05957-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5957"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05957-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involved human participants and was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (reference number ZZ2026-0222-01), and followed the guidelines of the Declaration of Helsinki.Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"714"}}